NCT06307262Recruiting
European Registry of Transcatheter Repair for Tricuspid Regurgitation
European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR)
Source: ClinicalTrials.gov · Last updated 15 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 27 Feb 2024
- Start date
- 23 Oct 2023
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- LMU Klinikum
- Diseases
- Heart failure
- NCT number
- NCT06307262
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 23 Oct 2023 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients treated with one of the following transcatheter devices for TV repair or replacement: PASCAL, TriClip, TricValve, Evoque, LuX-Valve
- Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| LMU Klinikum Coordinator of this site? Confirm its status | Munich | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.